Clinical Research Directory
Browse clinical research sites, groups, and studies.
LVAD Index and Clinical Outcomes in Continuous-Flow LVAD Patients
Sponsor: Gaziantep City Hospital
Summary
This single-center, observational study evaluated the LVAD index, defined as device-estimated pump flow divided by body surface area, in adult patients supported with continuous-flow left ventricular assist devices. The study included 34 patients with end-stage heart failure who had either an HVAD or HeartMate 3 device and were followed for six months. The study assessed the relationship between LVAD index and selected routine biochemical markers related to hepatic and renal status, including ALT, AST, LDH, BUN, and creatinine. The study also evaluated whether LVAD index was associated with rehospitalization during follow-up.
Official title: Association of LVAD Index With Selected Hepatic and Renal Biochemical Markers and Rehospitalization in HVAD and HeartMate 3 Continuous-Flow Left Ventricular Assist Devices
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
34
Start Date
2022-10-01
Completion Date
2023-04-30
Last Updated
2026-06-08
Healthy Volunteers
No
Interventions
HeartWare Ventricular Assist Device
Patients in this group were supported with the HeartWare Ventricular Assist Device as part of routine clinical care. No device assignment or protocol-driven intervention was performed by the study investigators.
HeartMate 3 Left Ventricular Assist Device
Patients in this group were supported with the HeartMate 3 left ventricular assist device as part of routine clinical care. No device assignment or protocol-driven intervention was performed by the study investigators.
Locations (1)
Akdeniz University Faculty of Medicine
Antalya, Turkey (Türkiye)